composition
Each injection contains Rituximab 100 mg/10 mL and Rituximab 500 mg/50 mL concentrate for solution for infusion in a single-use vial
indications
Non-Hodgkin's Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL) and Rheumatoid Arthritis (RA)
Therapeutic Focus
Oncology
